Raymond James Financial Services Advisors, Inc. Lexaria Bioscience Corp. Transaction History
Raymond James Financial Services Advisors, Inc.
- $66.3 Billion
- Q1 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 39,550 shares of LEXX stock, worth $109,948. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,550Holding current value
$109,948% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LEXX
# of Institutions
26Shares Held
889KCall Options Held
0Put Options Held
0-
Invenomic Capital Management LP Boston, MA473KShares$1.32 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA99.3KShares$276,1590.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA85.2KShares$236,7330.0% of portfolio
-
State Street Corp Boston, MA39.3KShares$109,2560.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX26.6KShares$74,0200.02% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $16.5M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...